Case details

Court: ded
Docket #: 1:12-cv-00465
Case Name: OSI Pharmaceuticals LLC et al v. Roxane Laboratories Inc.
PACER case #: 48541
Date filed: 2012-04-13
Date terminated: 2013-09-16
Assigned to: Judge Sue L. Robinson
Case Cause: 35:271 Patent Infringement
Nature of Suit: 830 Patent
Jury Demand: None
Jurisdiction: Federal Question

Parties

Represented Party Attorney & Contact Info
OSI Pharmaceuticals LLC
Plaintiff
 
Jack B. Blumenfeld
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
(302) 658-9200
Email: jbbefiling@mnat.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Maryellen Noreika
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street
P.O. Box 1347
Wilmington, DE 19899
(302) 658-9200
Email: menefiling@mnat.com
ATTORNEY TO BE NOTICED
Pfizer Inc.
Plaintiff
 
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Maryellen Noreika
(See above for address)
ATTORNEY TO BE NOTICED
Genentech Inc.
Plaintiff
 
Jack B. Blumenfeld
(See above for address)
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Maryellen Noreika
(See above for address)
ATTORNEY TO BE NOTICED
Roxane Laboratories Inc.
Defendant
 
Richard K. Herrmann
Morris James LLP
500 Delaware Avenue, Suite 1500
P.O. Box 2306
Wilmington, DE 19899-2306
(302) 888-6800
Email: rherrmann@morrisjames.com
LEAD ATTORNEY
ATTORNEY TO BE NOTICED

Keith A. Zullow
Email: kzullow@goodwinprocter.com
PRO HAC VICE
ATTORNEY TO BE NOTICED

Marta E. Gross
Email: mgross@goodwinprocter.com
PRO HAC VICE
ATTORNEY TO BE NOTICED

Documents

Date Filed Document # Attachment # Short Description Long Description Upload date SHA1 hash
2012-04-13 1 0 COMPLAINT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-1055925.) - filed by Pfizer Inc., OSI Pharmaceuticals LLC, Genentech Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(dmp, ) (Entered: 04/13/2012) 2012-04-13 11:09:40 20c1d050987ff7a180a0faccbf830757cd11cc0d
2012-04-13 2 0 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dmp, ) (Entered: 04/13/2012)
2012-04-13 3 0 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/12/2012. Date of Expiration of Patent: 11/08/2018 for RE41,065, 11/09/2020 for 6,900,221, 11/09/2020 for 7,087,613.Thirty Month Stay Deadline: 9/12/2014. (dmp, ) (Entered: 04/13/2012)
2012-04-13 4 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,065 E; 6,900,221 B1; 7,087,613 B2;. (dmp, ) (Entered: 04/13/2012)
2012-04-13 5 0 Disclosure Statement pursuant to Rule 7.1 filed by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc. identifying Corporate Parent Roche Holdings Inc., Other Affiliate Novartis AG, Other Affiliate Roche Holdings Ltd. for Genentech Inc.; Corporate Parent Astellas US LLC, Other Affiliate Astellas US Holding Inc., Other Affiliate Astellas Pharma Inc. for OSI Pharmaceuticals LLC. (dmp, ) (Entered: 04/13/2012)
2012-04-24 6 0 DECLARATION OF MAILING (as to service on Roxane Laboratories, Inc.) by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc.. (Attachments: # 1 Exhibit A & B)(Noreika, Maryellen) (Entered: 04/24/2012)
2012-05-02 7 0 STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to June 4, 2012 - filed by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc., Roxane Laboratories Inc.. (Herrmann, Richard) (Entered: 05/02/2012)
2012-06-04 8 0 ANSWER to 1 Complaint, and Defenses by Roxane Laboratories Inc..(Herrmann, Richard) (Entered: 06/04/2012)
2012-06-04 9 0 Disclosure Statement pursuant to Rule 7.1 filed by Roxane Laboratories Inc. identifying Corporate Parent Boehringer Ingelheim Corporation for Roxane Laboratories Inc... (Herrmann, Richard) (Entered: 06/04/2012)
2012-06-07 10 0 Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 6/27/2012 at 11:30 AM before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 6/7/2012. (fms) (Entered: 06/07/2012)
2012-06-11 11 0 MOTION for Pro Hac Vice Appearance of Attorney Marta E. Gross and Attorney Keith A. Zullow - filed by Roxane Laboratories Inc.. (Herrmann, Richard) (Entered: 06/11/2012)
2012-06-21 12 0 NOTICE OF SERVICE of Plaintiffs' Initial Disclosures by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc..(Noreika, Maryellen) (Entered: 06/21/2012)
2012-06-26 13 0 NOTICE OF SERVICE of Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) by Roxane Laboratories Inc..(Herrmann, Richard) (Entered: 06/26/2012)
2012-06-26 14 0 PROPOSED ORDER -- SCHEDULING ORDER -- by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc.. (Attachments: # 1 Letter to The Honorable Sue L. Robinson)(Blumenfeld, Jack) (Entered: 06/26/2012)
2012-06-26 15 0 MOTION for Pro Hac Vice Appearance of Attorney Brian J. Prew - filed by Roxane Laboratories Inc.. (Herrmann, Richard) (Entered: 06/26/2012)
2012-06-28 16 0 PROPOSED ORDER Regarding Scheduling by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc., Roxane Laboratories Inc.. (Attachments: # 1 Letter to Judge Robinson)(Blumenfeld, Jack) (Entered: 06/28/2012)
2012-07-03 17 0 MOTION for Pro Hac Vice Appearance of Attorney Benjamin C. Hsing and Sapna W. Palla - filed by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc.. (Noreika, Maryellen) (Entered: 07/03/2012)
2012-07-05 18 0 ORDER Setting Teleconference (Plaintiff's counsel shall initiate the call ): A Telephone Conference is set for 7/16/2012 at 02:00 PM before Judge Sherry R. Fallon to discuss ADR. Signed by Judge Sherry R. Fallon on 7/5/2012. (lih) (Entered: 07/05/2012)
2012-07-17 19 0 ORDER Setting Status Teleconference (Counsel for plaintiffs shall initiate the call ): A Status Teleconference is set for 10/29/2012 at 02:00 PM before Judge Sherry R. Fallon. Signed by Judge Sherry R. Fallon on 7/17/2012. (lih) (Entered: 07/17/2012)
2012-08-01 20 0 Letter to The Honorable Sherry R. Fallon from Jack B. Blumenfeld regarding referring case to another magistrate. (Blumenfeld, Jack) (Entered: 08/01/2012)
2012-08-03 21 0 ORDER Setting Teleconference : A Telephone Conference is set for 8/27/2012 at 11:00 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 8/3/2012. (dlk) (Entered: 08/03/2012)
2012-08-03 22 0 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for the Production of Documents and Things to Roxane Laboratories, Inc. and (2) Plaintiffs' First Set of Interrogatories to Roxane Laboratories, Inc. by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc..(Noreika, Maryellen) (Entered: 08/03/2012)
2012-09-04 23 0 NOTICE OF SERVICE of Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-8) and Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-31) by Roxane Laboratories Inc..(Matterer, Mary) (Entered: 09/04/2012)
2012-09-18 24 0 ORDER Setting Teleconference: A Telephone Conference is set for 11/26/2012 at 03:30 PM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 9/18/2012. (dlk) (Entered: 09/18/2012)
2013-03-25 25 0 STIPULATION TO EXTEND TIME for the parties to exchange lists of claim terms which they believe need construction to April 8, 2013 - filed by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc., Roxane Laboratories Inc.. (Matterer, Mary) (Entered: 03/25/2013)
2013-04-17 26 0 Letter to The Honorable Sue L. Robinson from Jack B. Blumenfeld regarding Joint Claim Construction Statement and Claim Charts. (Blumenfeld, Jack) (Entered: 04/17/2013)
2013-09-12 27 0 STIPULATION of Dismissal -- Consent Order of Dismissal -- by Genentech Inc., OSI Pharmaceuticals LLC, Pfizer Inc., Roxane Laboratories Inc.. (Blumenfeld, Jack) (Entered: 09/12/2013)
2013-09-16 28 0 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,065 E; 6,900,221 B1; 7,087,613 B2. (Attachments: # 1 Consent Order of Dismissal)(nmfn) (Entered: 09/16/2013)